Biomedical Research Related Content

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.

Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport discuss the impact of vitamin D in regulating immune tolerance and foetal development in pregnancy.

Here, Lifescience Legal Design discuss the legal status of CBD and hemp in the European Union.

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.

A study recently identified 21 existing drugs that could improve the effect of remdesivir.

Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.

A promising idea for lung cancer treatment has been developed by researchers at Lund University.

Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.

Professor Shinichi Tokuno discusses voice biomarkers, and the application in the field of assisted driving for the elderly.

Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.

János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.

Professors Alan Thornhill and Darren Griffin of the University of Kent call for more qualified diagnostic labs to be used in battle against Covid.

Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.

Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.

David Goff, MD, PhD, Director, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the National Institutes of Health in the U.S., introduces the work of the organisation and his thoughts on supporting heart and vascular health research.

Dr. Yuping Wang and Dr. David F. Lewis from LSUHSC-Shreveport discuss how to reduce hypertensive disorders in human pregnancy.

L. Maximilian Buja, MD, Professor of Pathology and Laboratory Medicine at McGovern Medical School, The University of Texas Health Science Center at Houston, turns the spotlight onto medical education both past and present.

Researchers have found that people who use social media for news are more likely to experience vaccine misinformation.

David S. Wishart discusses metabolomics, how the field is breaking into biochemical mysteries and the “dark metabolome”.